Shop All
Age-related macular degeneration (AMD) is the leading cause of vision loss in adults over 50, driven by oxidative stress to retinal pigment epithelium (RPE), drusen accumulation, complement system dysregulation, and choroidal neovascularization. Learn how sea moss zinc is central to the AREDS2 formula (proven to slow AMD progression by 25%), how it supports retinal pigment epithelium Cu/Zn-SOD antioxidant defense, how its anti-inflammatory fucoidan may reduce complement-driven drusen formation, how selenium supports glutathione peroxidase protection of photoreceptor outer segments, and how its carotenoid content contributes to macular pigment optical density. Critical: AMD requires ophthalmologist monitoring; established AMD with geographic atrophy or neovascularization needs anti-VEGF injection therapy -- sea moss is supplemental antioxidant support only.
For the complete science-backed breakdown, including mechanisms, dosing, timing, and safety considerations, read our full guide:
Sea Moss for Macular Degeneration: Antioxidants, Zinc, and Retinal Pigment Protection
Key topics covered:
- The specific compounds in sea moss relevant to this condition
- Mechanistic pathways (not just anecdotal claims)
- Evidence-based dosing protocols and timing
- Drug interactions and contraindications
- How to integrate with conventional medical care
- What results are realistic and on what timeline
